Company intelligence / Profile preview

Raybow Pharmaceutical

Brevard, North Carolina, United Statesraybow.com ↗

Ownership: Private
Employees: ~1500
Development stage: Commercial

Overview

Raybow provides contract R&D and manufacturing services for pharmaceutical companies globally. It has supported the development and commercial supply of APIs such as dorzagliatin for Type II diabetes. The company operates FDA-inspected facilities and offers expertise in green chemistry, high-end fluorine chemistry, asymmetric synthesis, glycosides, high potency synthesis, and biological enzyme technology. No proprietary clinical results as it does not develop its own drugs.

Therapeutic areas: Endocrinology
Modalities: Small moleculesAPIs (Active Pharmaceutical Ingredients)Specialty chemicals
Industry: Contract Manufacturing Organization

Partnerships

Hua Medicine – API supplier for dorzagliatin commercialization in China and globally

Beyond the preview

Go deeper on Raybow Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raybow Pharmaceutical.

Explore the full profile